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Background: The agreement between self-reported and proxy measures of health status in ill children is not well
established. This study aimed to quantify the variation in health-related quality of life (HRQOL) derived from young
patients and their carers using different instruments.
Methods: A hospital-based cross-sectional survey was conducted between August 2010 and March 2011. Children
with meningitis, bacteremia, pneumonia, acute otitis media, hearing loss, chronic lung disease, epilepsy, mild
mental retardation, severe mental retardation, and mental retardation combined with epilepsy, aged between five
to 14 years in seven tertiary hospitals were selected for participation in this study. The Health Utilities Index Mark 2
(HUI2), and Mark 3 (HUI3), and the EuroQoL Descriptive System (EQ-5D) and Visual Analogue Scale (EQ-VAS) were
applied to both paediatric patients (self-assessment) and caregivers (proxy-assessment).
Results: The EQ-5D scores were lowest for acute conditions such as meningitis, bacteremia, and pneumonia,
whereas the HUI3 scores were lowest for most chronic conditions such as hearing loss and severe mental
retardation. Comparing patient and proxy scores (n = 74), the EQ-5D exhibited high correlation (r = 0.77) while in
the HUI2 and HUI3 patient and caregiver scores were moderately correlated (r = 0.58 and 0.67 respectively). The
mean difference between self and proxy-assessment using the HUI2, HUI3, EQ-5D and EQ-VAS scores were 0.03,
0.05, -0.03 and −0.02, respectively. In hearing-impaired and chronic lung patients the self-rated HRQOL differed
significantly from their caregivers.
Conclusions: The use of caregivers as proxies for measuring HRQOL in young patients affected by pneumococcal
infection and its sequelae should be employed with caution. Given the high correlation between instruments, each
of the HRQOL instruments appears acceptable apart from the EQ-VAS which exhibited low correlation with the
others.
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Measuring health-related quality of life (HRQOL) is in-
creasingly used to quantify the effect of a health condi-
tion on an individual’s life, and to assess the impact of
health care interventions. Economic evaluations measure
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allocation. Utility scales usually range from 0 to 1, where
full health is assumed to have the value 1 and death the
value 0. Some HRQOL measures such as the Health
Utilities Index Mark 2 (HUI2), and Mark 3 (HUI3), and
EuroQoL Descriptive System (EQ-5D) allow negative
scores that express health states considered worse than
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HRQOL in young children. Firstly, children’s growth and
development changes rapidly, which may affect the base-
line measure of particular health dimensions such as self-
care, usual activity or communication ability [1,2]. At
present, there are no standard instruments for measuring
health status in this population. While the HUIs and EQ-
5D, generic health status instruments are recognised as
valid and reliable for eliciting health status in adults and
children aged over four years (for the HUIs and through
proxy-assessment) or 14 years (for the EQ-5D) [3-7], and
are widely used in cost-utility analysis (CUA) [1,8], their
application for younger age-groups is still controversial
[1]. Furthermore, HRQOL obtained using different instru-
ments can differ substantially even when measured in the
same person [9,10] a phenomenon that is particularly evi-
dent in young children. While some variation in HRQOL
scores obtained from different instruments is inevitable,
these can be tested in target populations in order to ex-
plore the extent of variation between them. Instruments
that provide widely differing outcomes might then be con-
sidered less appropriate for use in these populations.
A second challenge to the use of HRQOL instruments
with young children, is that these should ideally be com-
pleted by the target population, posing substantial chal-
lenges in very young responders. A review found that
only 2% of studies where children were the primary
beneficiaries of the intervention estimated HRQOL
scores directly from this age-group [1]. This is expected
given the greater difficulties children might face in ac-
curately describing their health condition during and
after illness episodes. In addition, some of the questions
might be too complex for young children to answer. As
a result, proxy-assessment, where children’s health status
is obtained through their caregivers, physicians, or adult
patients with similar health conditions, is applied
[11-14]. However, self- and proxy-assessed HRQOL
scores may vary, even when using the same tools
[12,13].
Based on this review, two potential sources of vari-
ation are present when assessing HRQOL in young chil-
dren: 1) variation due to the choice of instrument; 2)
variation between the measures obtained from patients
directly as opposed to their carers. The agreement be-
tween self-reported and proxy measures of health status
in ill children is not well established and there are no
clear guidelines as to whether this is acceptable practice
[12,13,15,16]. Where the use of a proxy is not appropri-
ate, better guidance is needed on the most appropriate
tools for health status measurement in young children.
This study explores the use of instruments for
HRQOL measurement in young children affected by in-
fectious diseases in Thailand, and is a part of a CUA of
10- and 13-valent pneumococcal conjugate vaccines.Assessment using various HRQOL instruments by the
caregivers and affected children (who are able to rate
their health status) can provide the necessary data to ad-
dress the above knowledge-gap.
The specific objectives of this study are to 1) quantify
the variation in scores derived from young patients and
their carers using different HRQOL instruments in dif-
ferent health conditions; 2) provide recommendations as
to whether it is appropriate to measure HRQOL of
paediatric patients using their caregivers’ assessments; 3)
where proxy assessment is not appropriate, identify
which instrument is most suitable for use in very young
children.
Methods
Study design and sample
The health conditions to be assessed in this study were se-
lected by a consortium of experts in paediatric infectious
disease, paediatric neurology, epidemiology, vaccinology,
and health economics. The list of conditions aimed to in-
clude the most common severe pneumococcal infections
and their sequelae that are likely to have the highest im-
pact on HRQOL. The final list included: 1) meningitis 2)
bacteremia, 3) pneumonia, 4) acute otitis media (AOM),
5) hearing loss, 6) chronic lung disease, 7) epilepsy, 8)
mild mental retardation (MMR), 9) severe mental retard-
ation (SMR), and 10) mental retardation combined with
epilepsy (MR + epilepsy).
We conducted a hospital-based cross-sectional survey
from August 2010 to March 2011 in seven public ter-
tiary hospitals in different parts of Thailand. The hospi-
tals were selected based on having a high number of
bacterial meningitis cases which was a relatively rare
condition but one with a high burden of disease. This
study was approved by the ethics committee of Queen
Sirikit National Institute of Child Health, Nopparat
Rajathanee Hospital, Maharat Nakhon Ratchasima Hos-
pital, Udonthani Hospital, Chiangrai Regional Hospital,
Hatyai Hospital, and Faculty of Medicine, Prince of
Songkla University. We calculated the sample size based
on a attempt to detect a mean difference of 0.05 of the
maximum of various scales for HRQOL for patient-
caregiver pairs with and an estimated standard deviation
(SD) of paired response difference of 0.03 [17], a power
of 80% with a significance level of 0.05, at least six pairs
were required for each health condition.
Health personnel from the study sites helped in the
identification of eligible patients and their caregivers.
Pneumococcal bacteremia, pneumococcal pneumonia
and bacterial meningitis cases were identified in the
paediatric wards. The case definition for these cases
conformed with the clinical criteria defined by the Case
Definitions for Infectious Conditions in Thailand [18] or
the International Classification of Diseases and Related
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chronic lung disease, epilepsy, MMR, SMR and MR +
epilepsy cases were identified in the paediatric clinics.
Relevant outpatient cases were classified into each health
condition according to physicians’ diagnosis, regardless
of diagnostic method. We selected all cases who met the
criteria during the data collection period.
Patients aged between five and 14 years in the selected
hospitals who were diagnosed with any single one of the
selected health conditions were enrolled. All school age
patients aged 7 years and above who were able to com-
municate were invited along with their caregivers to dir-
ectly participate in the study. For patients aged under
seven years and for patients who refused or were unable
to answer a series of questions, such as those with men-
tal retardation (MR), only caregivers were invited to par-
ticipate. Caregivers were excluded if they were unable to
answer the questions or unwilling to participate in the
study.
Consent was sought from a parent or guardian of the
identified patients prior to interviews and reviews of
paediatric medical records. The participants were
interviewed by interviewers using the Thai version of
HUIs and EQ-5D questionnaires. Although these instru-
ments can routinely be completed independently by pa-
tients, in the study both patients and caregivers were
interviewed face-to-face by well-trained interviewers
reading out the structured questionnaires and them-
selves completing the forms.
Study instruments
The HUI2, HUI3 and EQ-5D were selected as they have
been widely used in HRQOL measurement in children
and Thai versions have already been validated and ap-
proved by the Health Utilities Inc and the EuroQol
group, respectively. In addition, responses can be
converted into utility scores. The EQ-VAS is an integral
component of the EQ-5D questionnaire; however, we
examine it here independently of the primary descriptive
system. From our literature review, all of these scales
were reported to have minimal problem of floor and
ceiling effects with the exception of an important ceiling
effect in the case of EQ-5D [19-23].
The EQ-5D includes five dimensions (mobility, self-
care, usual activities, pain/discomfort, and anxiety/de-
pression) with three ordered levels of severity for each
dimension. The self-administered version of EQ-5D is
considered suitable for people aged 14 years and above.
An EQ-5D youth (EQ-5D-Y) version for children aged
between seven to 12 years has been developed but has
not been adapted to the Thai context. The EQ-VAS is a
standardised extension to the EQ-5D descriptive system.
It is a rating scale with a vertical 20 cm Visual Analogue
Scale (VAS) with the end points labelled best imaginablehealth state at the top and worst imaginable health state
at the bottom having numeric values of 100 and 0, re-
spectively. The standard version was used for all
subjects.
The HUI2 comprises seven dimensions (sensation,
mobility, emotion, cognition, self-care, and pain and fer-
tility) with four or five ordered levels of severity for each
dimension. The HUI3 was developed to address con-
cerns surrounding certain definitions in the HUI2 [24],
and is comprised of eight dimensions (vision, hearing,
speech, cognition, pain, emotion, ambulation, and dex-
terity) with five or six ordered levels of severity for each
dimension. Of the seven dimensions in HUI2, the fertil-
ity dimension was excluded, whereas the sensation di-
mension was split into vision, hearing and speech. We
used the validated Thai version ‘HUI23′ [25], which in-
cludes all 41 questions that comprise HUI2 (37 ques-
tions) and HUI3 (33 questions), and from which each
instrument can be used by selecting the relevant compo-
nents. The HUIs have been considered suitable for
people aged five years and above through proxy-
assessment.
Data analysis
A Thai algorithm was used to calculate the EQ-5D
scores [26] but a Canadian scoring function of HUIs was
used for HUI23 due to the lack of local data [27]. The
correlation between scores from different instruments
was calculated for patients and for caregivers, and the
correlation between scores from patients and caregivers
was calculated for different instruments. To determine
whether there were systematic differences in scores be-
tween instruments, we calculated for each health condi-
tion and overall HRQOL the mean score and its 95%
confidence interval (CI) using each of the HRQOL in-
struments in both paediatric patients where possible,
and in their caregivers. ANOVA was used to analyze the
source of variability of the scores. Differences in scores
between caregivers and patients were tested using paired
t-tests for the 28 condition-instrument combinations.
All statistical analyses were carried out in the open
source R software package [28].
Results
In total 173 cases were identified. None of the caregivers re-
fused to participate giving a 100% response rate. The num-
ber of respondents by health conditions is shown in Table 1.
A total of 74 paediatric patient-caregiver complete sets par-
ticipated in this study. Additionally, 99 caregivers partici-
pated with a corresponding patient that was either too sick
(all cases of MR and the majority of meningitis, pneumonia
and AOM, n = 53) or were too young (aged less than 7 years,
n = 46) to complete the questionnaire. The overall mean pa-
tient age was 10 (SD= 3). Males accounted for 62%. Among
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males accounted for only 13%. The duration for completing
the HUI23 was approximately eight minutes in both patients
and caregivers, significantly longer than for the EQ-5D +
VAS which took approximately three minutes.
Table 2 shows correlation coefficients among different in-
struments in the same subjects (both the patient and care-
giver) and between the same patient-caregiver pair using the
same instrument (highlighted in the bold). Most values indi-
cated relatively high or moderate correlation except the cor-
relation coefficients between the EQ-VAS and HUIs, both
within the same person and between patient and caregiver












Values in bold correspond to the correlation coefficients of the scores between the
found to be non-significant (P > 0.05).The HRQOL scores obtained from all caregivers are
shown in Figure 1. The EQ-5D scores are the lowest
for seven of 10 health conditions i.e., meningitis,
bacteremia, pneumonia, AOM, chronic lung disease,
epilepsy and MMR, whereas the HUI3 gave the low-
est scores for three health conditions i.e., hearing loss,
SMR and MR + epilepsy. The HRQOL scored by
paediatric patients themselves are shown in Figure 2.
Similarly, the EQ-5D scores were lowest among four
of the seven health conditions in which patients could
respond i.e., meningitis, bacteremia, pneumonia and
epilepsy. Likewise, the HUI3 scores were lowest in
the remaining three conditions. We ran a factor ana-
lysis for the mean of each measure on each health
condition. Two factors were identified in both care-
giver and patient data sets. In both groups, the first
factor included meningitis, bacteremia, pneumonia,
chronic lung disease and epilepsy. The second factor
had less consistent components. The total variances
of these means explained by the two factors were
94% in caregivers and 98% in patients.
Table 3 illustrates the source of variation in
HRQOL scores in the two data sets. Using data from
the complete sets, variation within the same patient-
caregiver pair was small and not significant (P = 0.59).
Variation contributed by difference in the health con-
ditions and instruments were highly significant in
both data sets. When accounting for interaction be-
tween the health conditions and instruments, the P
was small indicating that both health conditions and
instruments were not acting independently from each
other.
Table 4 shows the breakdown of differences within
caregiver-patient sets by health condition and instru-
ments. HRQOL reported by paediatric patients were
slightly and non-significantly higher than thosearegivers using 4 HRQOL instruments (N = 74)
Scores from patient
S HUI2 HUI3 EQ-5D EQ-VAS
0.58 0.57 0.56 0.20a
0.58 0.67 0.59 0.24
0.40 0.44 0.77 0.49




patients and the caregivers using the same instruments. aThe correlation is














EQ−5D HUI3 EQ−VAS HUI2
Utility scores
Chronic lung
Figure 1 Mean scores and 95% CI obtained in caregivers using 4 HRQOL instruments (proxy-assessment).
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detected within the pairs was for hearing loss using
HUI3 and chronic lung disease using EQ-5D.
Discussion
This is the first study considering methodological as-
pects of children’s HRQOL instruments in the Thai con-
text and results of this study can be useful for guiding
future economic evaluations or outcome studies in this
and other settings. In this analysis, we address two major
















Figure 2 Mean scores and 95% CI obtained in paediatric patients usinas proxies for children’s HRQOL measures, and the use
of different HRQOL instruments across health condi-
tions in young patients.
The variation in HRQOL derived from patients compared
to their caregivers
We observed disparity in HRQOL derived from young
patients and caregivers using all instruments, and the
mean of differences exceeded 0.03, a difference that has
been considered to be clinically significant by previous
investigators [7,9,29]. Likewise, the data in Table 4M Hearing loss Chronic lung Epilepsy
 conditions
UI3 EQ−VAS HUI2
g 4 HRQOL instruments (self-assessment).
Table 3 Comparison of mean scores by sources
Df SS MS F P-value
From caregivers and patients complete sets
Assessor 1 0.02 0.02 0.28 0.59
Health condition 6 4.02 0.67 9.57 <0.001
Instrument 3 3.85 1.28 18.31 <0.001
Health condition : instrument 18 2.99 0.17 2.49 <0.001
Residuals 581 40.66 0.07
From sets with caregivers only
Health condition 9 15.29 1.70 27.38 <0.001
Instrument 3 3.51 1.05 16.92 <0.001
Health condition : instrument 27 3.12 0.12 1.86 <0.01
Residuals 652 40.47 0.06
Kulpeng et al. BMC Pediatrics 2013, 13:122 Page 6 of 9
http://www.biomedcentral.com/1471-2431/13/122suggest that the difference between patients and care-
givers was in the majority of health conditions of a mag-
nitude which would be regarded as clinically meaningful
though not statistically significant (except for hearing
loss and chronic lung disease using particular instru-
ments). The largest gap was found in hearing loss.
Health conditions relating to sensory impairment such
as hearing loss might be more challenging in proxy-
assessment than objective measures such as mobility.
The variation in HRQOL scores derived from patients
compared to their caregivers was also associated with
HRQOL instruments. The HUIs and EQ-5D scores had
good correlation within patient-caregiver pairs, a finding
that is also compatible with other studies [14,30,31]. TheTable 4 Mean of difference of scores between caregivers and
Health conditions N HUI2
Meningitis 7 −0.07
(95%CI) (−0.17 to 0.03)
Bacteremia 9 0.05
(95%CI) (−0.15 to 0.24)
Pneumonia 8 −0.08
(95%CI) (−0.22 to 0.07)
AOM 7 0.05
(95%CI) (−0.09 to 0.19)
Hearing loss 15 0.14
(95%CI) (−0.01 to 0.28)
Chronic lung 12 0.00
(95%CI) (−0.11 to 0.12)
Epilepsy 16 −0.01
(95%CI) (−0.08 to 0.07)
Overall 74 0.03
(95%CI) (−0.02 to 0.07)
aStatistically significant (P < 0.05) different utility score for caregivers compared withdegree of caregiver-patient correlation in the HUI3 was
higher than in the HUI2 in our study. The EQ-VAS in
both patients and caregivers had the lowest correlation
with other measures. This may be because the EQ-VAS
involves a different task (valuation of health state)
whereas for the other three measures the respondents
were asked to describe their own or the child’s health
state.
The use of different HRQOL instruments across health
conditions in young patients
As would be expected, all instruments offered different
HRQOL scores for the same health condition. For both




(−0.21 to 0.07) (−0.58 to 0.05) (−0.09 to 0.20)
0.13 0.08 0.01
(−0.18 to 0.44) (−0.13 to 0.29) (−0.19 to 0.21)
−0.02 −0.05 −0.05
(−0.13 to 0.10) (−0.15 to 0.05) (−0.28 to 0.17)
0.07 −0.08 −0.06
(−0.09 to 0.24) (−0.20 to 0.04) (−0.23 to 0.11)
0.24 0.08 0.01
(0.03 to 0.46)a (−0.03 to 0.19) (−0.12 to 0.14)
0.03 −0.11 −0.03
(−0.09 to 0.14) (−0.22 to −0.00)a (−0.16 to 0.09)
0.00 −0.00 −0.02
(−0.11 to 0.12) (−0.06 to 0.06) (−0.10 to 0.06)
0.05 −0.03 −0.02
(−0.00 to 0.11) (−0.07 to 0.02) (−0.06 to 0.02)
patients.
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to provide the lowest. The EQ-5D yielded the lowest
HRQOL scores compared to other instruments in acute
diseases, whereas the HUI3 provided the lowest score in
most of chronic conditions. These findings are consist-
ent with two other studies [10,32]. Our study, however,
found that for epilepsy the HRQOL score was the lowest
using the EQ-5D, as opposed to HUI3 in another study
[10]. It is noteworthy that the Thai algorithm used for
EQ-5D was derived from the Time Trade-Off (TTO)
technique, whereas HUI scoring function was obtained
from the Standard Gamble (SG) technique and VAS.
This difference might influence the results because pre-
vious studies indicated that TTO produced lower utility
scores than SG in Asian and other population groups
[33-36]. Moreover, the absence of a Thai specific scoring
function for HUIs could have affected the results as
people in different countries are likely to have different
health state preferences [32].
The EQ-5D in particular may not be sufficiently sensi-
tive for measuring HRQOL in patients with sensory im-
pairment as it does not include a sensory dimension
[32,37-39]. SG and TTO have been used to measure util-
ity directly in hearing impaired persons [40]. The SG
and TTO, however, are time-consuming and conceptu-
ally challenging. Furthermore, the HUI3 has proven to
be valid and acceptable for measuring HRQOL in hear-
ing impaired populations [10,32,37-39,41]. For health
conditions associated with sensory impairment, there-
fore, self-reported assessment of health status using the
HUI3 is the optimal choice. The EQ-VAS score obtained
from patients and caregivers is similar, yet correlation
between scores rated by this and other instruments was
low. Furthermore, given the general difficulties in using
the EQ-VAS in people who may not understand its
quantitative properties [33,42,43], it may not be appro-
priate for very young patients. This was supported by a
prior study showing that 13% of adult patients found it
difficult to use [43].
In addition, the degree of correlation between instru-
ments is used to examine their agreement (convergent
validity). The HUIs and EQ-5D scores had a moderate
to high correlation within the same subject, confirming
findings from previous studies [44-46]. The HUI2 and
HUI3 had very high correlation; this is mainly because
there is much duplication in these tools (30 of 40 ques-
tions in HUI23 are identical). The HUI3 is claimed to be
superior to the HUI2 as it was developed to improve
structural independence so that each domain would
yield specific information [24,47].
Study limitations
In addition to the limitation of incomplete pairs of
patient-caregiver sets, another methodological concernis the fact that subjects were recruited at tertiary hospi-
tals where patients are likely to be in an acute phase of
their illness and the impact on certain HRQOL dimen-
sions such as mobility may not be readily apparent. We
argue that this did not introduce a substantial bias since
patients in most of our pre-specified conditions are usu-
ally hospitalized. The shortcoming may be more serious
in health states associated with chronic disability as pa-
tient and proxy assessment of their HRQOL once back
home may be different from when they are hospitalized
[48]. Lastly, although this study selected patients with a
single condition, there may have been co-morbidities
that were undiagnosed during data collection that may
have influenced HRQOL scores.Conclusions
Our data imply that use of caregivers as proxies for
measuring HRQOL in young patients affected by
pneumococcal infection and its sequelae should be
employed with caution. Given the high correlation be-
tween instruments, each of the HRQOL instruments ap-
pears acceptable apart from the EQ-VAS which
exhibited low correlation with the others. For conditions
associated with sensory impairment we would recom-
mend the use of HUI3 due to its explicit inclusion of
this dimension.
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